OCG plans to add a product manager who will work to support sales of the Synergy Cervical disc in the EMEA regions, according to a Sept. 12 news release. It is the only artificial cervical disc with a 6-degree lordotic core. It is designed for patients with degenerative disc disease causing radiculopathy or myelopathy.
The Synergy disc is commercially available in Australia, New Zealand, Europe and Canada. It is designated for investigational use in the U.S.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
